MacroGenics (MGNX) reported a 17.8% decline in revenue to $10.8 million for the quarter ending June 2024, with an EPS of -$0.89 compared to -$0.36 a year ago.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
MacroGenics (MGNX) reported a 17.8% decline in revenue to $10.8 million for the quarter ending June 2024, with an EPS of -$0.89 compared to -$0.36 a year ago.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.